Compare Sequential and Quadruple Therapy for the Eradication of Helicobacter Pylori in Korea
Status:
Completed
Trial end date:
2016-04-01
Target enrollment:
Participant gender:
Summary
1. To compare 10-day sequential therapy and 14-day modified bismuth quadruple therapy and
to establish more effective first-line regimen for the eradication of Helicobacter
pylori in Korea.
2. To evaluate the effect of H. pylori eradication therapy on the symptom improvement of
functional dyspepsia
Phase:
N/A
Details
Lead Sponsor:
Seoul National University Bundang Hospital
Collaborators:
Chong Kun Dang Pharmaceutical CJ HealthCare Corporation Green Cross Corporation HK inno.N Corporation SK Chemicals Co., Ltd. SK Chemicals Co.,Ltd.